ISB News

Tackling Lyme Disease with Immunity

It’s Lyme disease season in many areas of the United States, including the Northeast, the Midwest, and some places on the West Coast. About 30,000 Lyme disease cases are reported to the Centers for Disease Control and Prevention each year, but that number is likely far lower than the actual number of people diagnosed each year. Some estimates suggest that nearly 500,000 people get Lyme disease annually in the U.S. alone.

ISB Associate Professor Dr. Naeha Subramanian participated in ISB’s latest Research Roundtable event. Lyme disease is just one of the research areas studied by the Subramanian Lab. Subramanian delivered a presentation called “Tackling Lyme Disease with Immunity,” which you can watch here or by clicking play on the video at the top of this story.

Research Roundtables

ISB is hosting a series of Research Roundtable conversations throughout 2021 that will feature our leading scientists discussing their latest research. These events are designed for the novice scientist and the expert alike, and are open to anyone interested in the topics. Featured scientists will also answer your questions.

Next up in our series is Dr. Andrew Magis, who on September 21 will discuss identifying markers for cancer years before diagnosis (sign up here).

Past Research Roundtable events have featured ISB Co-founder Dr. Lee Hood, microbiome specialist and ISB Assistant Professor Dr. Sean Gibbons, and Alzheimer’s disease expert and ISB Senior Research Scientist Dr. Jared Roach. You can read about their talks and watch their presentations here, here and here, respectively.

Recent Articles

  • Microbiome and weight loss

    Can You Lose Weight? Ask Your Microbiome

    The strongest associations with weight loss success or failure – independent of BMI – are found in the genetic capacity of the gut microbiome. These new findings open the door to diagnostic tests that can identify people likely to lose weight with healthy lifestyle changes and those who might need more drastic interventions.

  • Drs. Jim Heath, Yapeng Su and Jihoon Lee

    Metabolic Changes in Plasma and Immune Cells Associated with COVID-19 Severity, May Predict Patient Survival

    Researchers from Institute for Systems Biology (ISB), Fred Hutchinson Cancer Research Center and other organizations have uncovered underlying metabolic changes that regulate how immune cells react to COVID-19. These findings are associated with COVID-19 severity and may predict patient survival. The work was published in the journal Nature Biotechnology.

  • 2021 ISB Microbiome Series

    2021 ISB Virtual Microbiome Series Announced

    Our multi-day microbiome-themed virtual course and symposium is back by popular demand! ISB is hosting a two-day course on October 13 & 14, followed by a symposium on October 15. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious person from across the globe.